Insider · CIK 0001905593
Lorraine Pamela D'Alessio
Files at MGRX (MANGOCEUTICALS, INC.). First filing -, latest -.
In brief
Lorraine Pamela D'Alessio files SEC Form 4 as director at MGRX (MANGOCEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lorraine Pamela D'Alessio has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | MGRX MANGOCEUTICALS, INC. | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 136,667 | Sep 12, 2025 |
| Apr 10, 2025 | MGRX MANGOCEUTICALS, INC. | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 36,667 | Apr 11, 2025 |
Questions about Lorraine Pamela D'Alessio
Answered from the filings on this page, as of the latest one.
Is Lorraine Pamela D'Alessio buying or selling?
Lorraine Pamela D'Alessio has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lorraine Pamela D'Alessio's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lorraine Pamela D'Alessio has 0.
Where does Lorraine Pamela D'Alessio file Form 4?
Lorraine Pamela D'Alessio has filed Form 4 at MGRX (MANGOCEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.